Monoclonal B-cell lymphocytosis: definitions and natural history

References

• Marti G E, Rawstron A C, Ghia P, Hillmen P, Houiston R S, Kay N, et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005; 130: 325–332
   PubMed Web of Science ®Google Scholar
• Hallek M, Cheson B D, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008; 111: 5446–5456
   PubMed Web of Science ®Google Scholar
• Harris N L, Jaffe E S, Diebold J, Flandrin G, Muller-Hermelink H K, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849
   PubMed Web of Science ®Google Scholar
• Vogt R F, Shim Y K, Middleton D C, Buffler P A, Campolucci S S, Lybarger J A, et al. Monoclonal B-cell lymphocytosis as a biomarker in environmental health studies. Br J Haematol 2007; 139: 690–700
   PubMed Web of Science ®Google Scholar
• Marti G, Abbasi F, Raveche E, Rawstron A C, Ghia P, Aurran T, et al. Overview of monoclonal B-cell lymphocytosis. Br J Haematol 2007; 139: 701–708
   PubMed Web of Science ®Google Scholar
• Rawstron A, Green M, Kuzmicki A, Kennedy B, Fenton J, Evans P, et al. Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 2002; 100: 635–639
   PubMed Web of Science ®Google Scholar
• Ghia P, Prato G, Scielzo C, Stella S, Geuna M, Guida G, et al. Monoclonal CD5+ and CD5− B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood 2004; 103: 2337–2342
   PubMed Web of Science ®Google Scholar
• Rawstron A, Yuille M, Fuller J, Cullen M, Kennedy B, Richards S, et al. Inherited predispoition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion. Blood 2002; 100: 2289–2290
   PubMed Web of Science ®Google Scholar
• Marti G, Carter P, Abbasi F, Washington G, Jain N, Zenger V, et al. B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia. Cytometry B 2003; 52: 1–12
   PubMedGoogle Scholar
• Shanafelt T D, Kay N E, Call T G, Zent C S, Jolinek D F, Laplant B, et al. MBL or CLL: Which classification best categorizes the clinical course of patients with an absolute lymphocyte count ≥5 × 109 L−1 but a B-cell lymphocyte count <5 × 109 L−1. Leuk Res 2008; 32: 1458–1461
   PubMed Web of Science ®Google Scholar
• Shim Y K, Vogt R F, Middleton D, Abbasi F, Slade B, Lee K Y, et al. Prevalence and natural history of monoclonal and polyclonal B-cell lymphocytosis in a residential adult population. Cytometry B Clin Cytom 2007; 72: 344–353
   PubMed Web of Science ®Google Scholar
• Rawstron A C, Bennett F L, O'Connor S J, Kwok M, Fenton J A, Plummer M, et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 2008; 359: 575–583
   PubMed Web of Science ®Google Scholar
• Fung S S, Hillier K L, Leger C S, Sandhu I, Vickars L M, Galbraith P F, et al. Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis. Leuk Lymphoma 2007; 48: 1087–1091
   PubMed Web of Science ®Google Scholar
• Faguet G B, Agee J F, Marti G E. Clone emergence and evolution in chronic lymphocytic leukemia: characterization of clincial, laboratory, and immunophenotypic profiles of 25 patients. Leuk Lymphoma 1992; 6: 345–356
   Web of Science ®Google Scholar
• Hamblin T J, Davis Z, Gardiner A, Oscier D G, Stevenson F K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848–1854
   PubMed Web of Science ®Google Scholar
• Shanafelt T D, Witzig T E, Fink S R, Jenkins R B, Paternoster S F, Smoley S A, et al. Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia. J Clin Oncol 2006; 24: 4634–4641
   PubMed Web of Science ®Google Scholar
• Rassenti L Z, Jain S, Keating M J, Wierda W G, Grever M R, Byrd J C, et al. Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia. Blood 2008; 112: 1923–1930
   PubMed Web of Science ®Google Scholar
• Maddocks-Christianson K, Hanson C A, Jenkins G, Zent C S, Slager S L, Call T G, et al. Molecular prongostic factors and outcome among a cohort of patients with monoclonal B-cell lymphcytosis (MBL). Blood 2007; 110 (abstract #748)
   Google Scholar
• Shanafelt T D, Bowen D, Venkat C, Slager S L, Zent C S, Kay N, et al. Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients. Br J Haematol 2007; 139: 255–264
   PubMed Web of Science ®Google Scholar
• Shanafelt T D, Bowen D A, Venkat C, Slager S L, Zent C S, Kay N E, et al. The physician-patient relationship and quality of life: Lessons from chronic lymphocytic leukemia. Leuk Res 2009; 33: 263–270
   PubMed Web of Science ®Google Scholar
• Kyle R A, Rajkumar S V. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression. Br J Haematol 2007; 139: 730–743
   Google Scholar
• Shanafelt T D, Kay N E, Jenkins G, Call T G, Zent C S, Jelinek D F, et al. B-cell count and survival: differentiating chronic lymphocytic leukemia (CLL) from monoclonal B-cell lymphocytosis (MBL) based on clinical outcome. Blood 2008, [Epub ahead of print, November 2008]
   Web of Science ®Google Scholar